Correlation between tumor proliferation and tumor tissue level of urokinase-type plasminogen activator. 1993

H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
Second Department of Surgery, Hamamatsu University School of Medicine, Japan.

We established a xenotransplanted human colon cancer strain, TK-3, which produces urokinase-type plasminogen activator (U-PA) and carcinoembryonic antigen (CEA) simultaneously. Immunohistochemical staining of U-PA revealed that U-PA was located in the cytoplasm of cancer cells. Using TK-3, we investigated whether the tissue level of U-PA changed when the tumor proliferated locally. The mice were divided into three groups: mice of group A, B and C were sacrificed at 4, 5 and 6 weeks after tumor inoculation, respectively. The tissue level of U-PA was 0.78 +/- 0.183 ng/mg protein in group A, 0.95 +/- 0.189 in group B and 1.13 +/- 0.311 in group C. The values of groups B and C increased significantly compared with those of group A, and the tumor weight in each group showed a similar increase. The level of plasminogen activator inhibitor type 2 also increased (0.14 +/- 0.078 ng/mg protein in group A, 0.17 +/- 0.096 in group B, 0.24 +/- 0.172 in group C). On the other hand, the tissue level of CEA did not change significantly (78 micrograms/g tissue in group A, 88 in group B, 76 tissue in group C), and no correlation was observed between the tissue levels of U-PA and CEA. These results suggest that U-PA plays an important role not only in metastasis, but also in local tumor proliferation, and that its biological action in the autocrine system is independent of CEA.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft

Related Publications

H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
December 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
December 1995, Protein engineering,
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
January 2007, The international journal of biochemistry & cell biology,
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
March 1991, The Journal of biological chemistry,
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
October 1988, Lancet (London, England),
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
February 1988, The Journal of biological chemistry,
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
January 1997, Oncology reports,
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
January 1997, Journal of vascular surgery,
H Konno, and T Tanaka, and Y Maruo, and N Nishino, and S Nakamura, and S Baba, and A Takada
March 1989, Thrombosis research,
Copied contents to your clipboard!